Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q2 2025 Earnings Call Transcript August 7, 2025
Xeris Biopharma Holdings, Inc. beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.03.
Operator: Hello, everyone, and thank you for joining the Xeris Biopharma Second Quarter 2025 Earnings Conference Call. My name is Sami, and I’ll be coordinating your call today. [Operator Instructions] I’ll now hand over to your host, Allison Wey, Senior Vice President of Investor Relations...
